Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs JPMorgan Nasdaq Equity Premium Income ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while JPMorgan Nasdaq Equity Premium Income ETF trades at $59.58 (market cap $43.97B). The key difference: JPMorgan Nasdaq Equity Premium Income ETF is the larger of the two by market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while JPMorgan Nasdaq Equity Premium Income ETF pays none. Which is the better fit depends on your goals.
| GEHC | JEPQ | |
|---|---|---|
Market Cap | $30.93B | $43.97B |
Volume | 5,033,451 | 6,284,829 |
Sector | Health | Income / Options Overlay |
52-Week High | $88.16 | $61.46 |
52-Week Low | $59.48 | $53.77 |
Enterprise Value | $39.39B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 67 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
JEPQ trades at $60.92 with minimal daily movement (-0.02%). The ETF maintains a neutral technical stance with bullish moving averages but mixed oscillators. Recent news highlights its role in income strategies, with articles noting its 11% estimated yield and positioning in AI-driven tech stocks. The fund's covered-call strategy generates monthly dividends but limits capital appreciation potential.
JEPQ offers high income generation through its Nasdaq-focused covered-call approach, appealing to retirees seeking monthly cash flow. However, investors face trade-offs between yield and growth potential, with performance tied to market volatility. Key risks include dependence on tech sector performance and variable dividend payments that fluctuate with market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About JPMorgan Nasdaq Equity Premium Income ETF
JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.
Read more on JEPQ →
